Bristol-Myers Squibb Company (BMY)
USD 56.84
(-1.41%)
USD 56.84
(-1.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 34.31 Billion USD | -2.97% |
| 2022 | 26.91 Billion USD | -3.55% |
| 2021 | 27.9 Billion USD | -2.31% |
| 2020 | 28.56 Billion USD | 135.05% |
| 2019 | 12.15 Billion USD | 11.55% |
| 2018 | 10.89 Billion USD | -3.23% |
| 2017 | 11.26 Billion USD | 13.26% |
| 2016 | 9.94 Billion USD | -8.96% |
| 2015 | 10.92 Billion USD | 6.72% |
| 2014 | 10.23 Billion USD | 15.82% |
| 2013 | 8.83 Billion USD | -2.69% |
| 2012 | 9.07 Billion USD | 5.43% |
| 2011 | 8.61 Billion USD | 11.73% |
| 2010 | 7.7 Billion USD | -13.02% |
| 2009 | 8.86 Billion USD | 4.49% |
| 2008 | 8.48 Billion USD | -11.69% |
| 2007 | 9.6 Billion USD | 2.84% |
| 2006 | 9.33 Billion USD | 0.1% |
| 2005 | 9.32 Billion USD | 4.49% |
| 2004 | 8.92 Billion USD | 6.85% |
| 2003 | 8.35 Billion USD | 12.36% |
| 2002 | 7.43 Billion USD | -2.09% |
| 2001 | 7.59 Billion USD | -7.57% |
| 2000 | 8.21 Billion USD | -13.58% |
| 1999 | 9.5 Billion USD | 6.45% |
| 1998 | 8.93 Billion USD | 6.46% |
| 1997 | 8.39 Billion USD | 9.44% |
| 1996 | 7.66 Billion USD | 10.1% |
| 1995 | 6.96 Billion USD | 16.65% |
| 1994 | 5.96 Billion USD | -5.09% |
| 1993 | 6.28 Billion USD | -5.2% |
| 1992 | 6.63 Billion USD | 16.2% |
| 1991 | 5.7 Billion USD | 8.1% |
| 1990 | 5.28 Billion USD | -6.46% |
| 1989 | 5.64 Billion USD | 25.77% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.21 Billion USD | -43.16% |
| 2024 Q3 | 4.35 Billion USD | 111.88% |
| 2024 Q1 | 7.41 Billion USD | 8.64% |
| 2023 Q4 | 6.82 Billion USD | 60.87% |
| 2023 Q3 | 4.24 Billion USD | -34.18% |
| 2023 Q2 | 6.44 Billion USD | 1.74% |
| 2023 FY | 26.11 Billion USD | -2.97% |
| 2023 Q1 | 6.33 Billion USD | -10.96% |
| 2022 Q4 | 7.11 Billion USD | 5.22% |
| 2022 Q1 | 6.5 Billion USD | -10.71% |
| 2022 Q2 | 6.52 Billion USD | 0.26% |
| 2022 FY | 26.91 Billion USD | -3.55% |
| 2022 Q3 | 6.76 Billion USD | 3.69% |
| 2021 Q1 | 6.4 Billion USD | -28.82% |
| 2021 FY | 27.9 Billion USD | -2.31% |
| 2021 Q2 | 7.7 Billion USD | 20.24% |
| 2021 Q3 | 7.58 Billion USD | -1.49% |
| 2021 Q4 | 7.28 Billion USD | -3.9% |
| 2020 Q3 | 6.69 Billion USD | 2.4% |
| 2020 Q1 | 6.33 Billion USD | 29.49% |
| 2020 Q2 | 6.53 Billion USD | 3.2% |
| 2020 FY | 28.56 Billion USD | 135.05% |
| 2020 Q4 | 8.99 Billion USD | 34.36% |
| 2019 Q4 | 4.89 Billion USD | 100.78% |
| 2019 Q3 | 2.43 Billion USD | 1.37% |
| 2019 Q2 | 2.4 Billion USD | 1.99% |
| 2019 Q1 | 2.35 Billion USD | -13.22% |
| 2019 FY | 12.15 Billion USD | 11.55% |
| 2018 Q4 | 2.71 Billion USD | 13.93% |
| 2018 Q1 | 2.23 Billion USD | -32.24% |
| 2018 Q2 | 3.56 Billion USD | 59.91% |
| 2018 FY | 10.89 Billion USD | -3.23% |
| 2018 Q3 | 2.38 Billion USD | -33.15% |
| 2017 Q4 | 3.29 Billion USD | 21.35% |
| 2017 FY | 11.26 Billion USD | 13.26% |
| 2017 Q3 | 2.71 Billion USD | -5.24% |
| 2017 Q2 | 2.86 Billion USD | 19.5% |
| 2017 Q1 | 2.39 Billion USD | -17.01% |
| 2016 FY | 9.94 Billion USD | -8.96% |
| 2016 Q4 | 2.88 Billion USD | 25.42% |
| 2016 Q2 | 2.52 Billion USD | 13.61% |
| 2016 Q3 | 2.3 Billion USD | -9.02% |
| 2016 Q1 | 2.22 Billion USD | -35.78% |
| 2015 Q2 | 3.02 Billion USD | 46.09% |
| 2015 Q4 | 3.46 Billion USD | 47.11% |
| 2015 Q3 | 2.35 Billion USD | -22.17% |
| 2015 FY | 10.92 Billion USD | 6.72% |
| 2015 Q1 | 2.07 Billion USD | -37.08% |
| 2014 FY | 10.23 Billion USD | 15.82% |
| 2014 Q3 | 2.21 Billion USD | -14.93% |
| 2014 Q2 | 2.59 Billion USD | 22.02% |
| 2014 Q1 | 2.13 Billion USD | -7.63% |
| 2014 Q4 | 3.29 Billion USD | 48.94% |
| 2013 FY | 8.83 Billion USD | -2.69% |
| 2013 Q4 | 2.3 Billion USD | 9.6% |
| 2013 Q3 | 2.1 Billion USD | -9.0% |
| 2013 Q2 | 2.31 Billion USD | 9.42% |
| 2013 Q1 | 2.11 Billion USD | -18.48% |
| 2012 Q1 | 1.93 Billion USD | -22.96% |
| 2012 Q3 | 2.18 Billion USD | -0.05% |
| 2012 Q2 | 2.19 Billion USD | 13.3% |
| 2012 FY | 9.07 Billion USD | 5.43% |
| 2012 Q4 | 2.59 Billion USD | 18.41% |
| 2011 FY | 8.61 Billion USD | 11.73% |
| 2011 Q1 | 2.07 Billion USD | -18.93% |
| 2011 Q2 | 2.21 Billion USD | 6.69% |
| 2011 Q3 | 2.19 Billion USD | -0.86% |
| 2011 Q4 | 2.5 Billion USD | 14.2% |
| 2010 Q1 | 2.02 Billion USD | 41.4% |
| 2010 Q3 | 1.94 Billion USD | -1.62% |
| 2010 Q4 | 2.56 Billion USD | 31.59% |
| 2010 FY | 7.7 Billion USD | -13.02% |
| 2010 Q2 | 1.97 Billion USD | -2.13% |
| 2009 Q1 | 2.31 Billion USD | -20.58% |
| 2009 Q2 | 2.16 Billion USD | -6.45% |
| 2009 FY | 8.86 Billion USD | 4.49% |
| 2009 Q3 | 2.14 Billion USD | -0.69% |
| 2009 Q4 | 1.43 Billion USD | -33.4% |
| 2008 Q4 | 2.91 Billion USD | 21.05% |
| 2008 Q1 | 2.34 Billion USD | -10.42% |
| 2008 Q2 | 2.41 Billion USD | 2.68% |
| 2008 FY | 8.48 Billion USD | -11.69% |
| 2008 Q3 | 2.4 Billion USD | -0.29% |
| 2007 Q3 | 2.39 Billion USD | 1.57% |
| 2007 Q1 | 2.23 Billion USD | -12.39% |
| 2007 FY | 9.6 Billion USD | 2.84% |
| 2007 Q4 | 2.62 Billion USD | 9.57% |
| 2007 Q2 | 2.35 Billion USD | 5.42% |
| 2006 Q2 | 2.27 Billion USD | -0.44% |
| 2006 FY | 9.33 Billion USD | 0.1% |
| 2006 Q1 | 2.28 Billion USD | -11.79% |
| 2006 Q4 | 2.55 Billion USD | 14.3% |
| 2006 Q3 | 2.23 Billion USD | -1.85% |
| 2005 FY | 9.32 Billion USD | 4.49% |
| 2005 Q2 | 2.28 Billion USD | 5.94% |
| 2005 Q4 | 2.58 Billion USD | 12.33% |
| 2005 Q3 | 2.3 Billion USD | 0.96% |
| 2005 Q1 | 2.15 Billion USD | -12.51% |
| 2004 Q1 | 2.13 Billion USD | -11.71% |
| 2004 FY | 8.92 Billion USD | 6.85% |
| 2004 Q3 | 2.14 Billion USD | -1.56% |
| 2004 Q4 | 2.46 Billion USD | 14.56% |
| 2004 Q2 | 2.18 Billion USD | 2.34% |
| 2003 Q2 | 2 Billion USD | 7.16% |
| 2003 Q3 | 2.06 Billion USD | 2.74% |
| 2003 FY | 8.35 Billion USD | 12.36% |
| 2003 Q4 | 2.41 Billion USD | 17.22% |
| 2003 Q1 | 1.87 Billion USD | -12.77% |
| 2002 FY | 7.43 Billion USD | -2.09% |
| 2002 Q1 | 1.69 Billion USD | -22.94% |
| 2002 Q2 | 1.86 Billion USD | 10.08% |
| 2002 Q3 | 1.8 Billion USD | -3.16% |
| 2002 Q4 | 2.14 Billion USD | 18.69% |
| 2001 FY | 7.59 Billion USD | -7.57% |
| 2001 Q1 | 1.71 Billion USD | -17.2% |
| 2001 Q2 | 1.86 Billion USD | 8.26% |
| 2001 Q3 | 1.73 Billion USD | -6.66% |
| 2001 Q4 | 2.2 Billion USD | 26.71% |
| 2000 Q2 | 2.57 Billion USD | 7.78% |
| 2000 Q3 | 2.02 Billion USD | -21.47% |
| 2000 Q4 | 2.07 Billion USD | 2.62% |
| 2000 Q1 | 2.39 Billion USD | -7.54% |
| 2000 FY | 8.21 Billion USD | -13.58% |
| 1999 Q2 | 2.4 Billion USD | 7.37% |
| 1999 FY | 9.5 Billion USD | 6.45% |
| 1999 Q4 | 2.58 Billion USD | 13.48% |
| 1999 Q1 | 2.24 Billion USD | -7.7% |
| 1999 Q3 | 2.27 Billion USD | -5.28% |
| 1998 Q3 | 2.14 Billion USD | -2.9% |
| 1998 Q2 | 2.2 Billion USD | 2.27% |
| 1998 FY | 8.93 Billion USD | 6.46% |
| 1998 Q4 | 2.42 Billion USD | 13.31% |
| 1998 Q1 | 2.15 Billion USD | -8.87% |
| 1997 Q4 | 2.36 Billion USD | 19.24% |
| 1997 FY | 8.39 Billion USD | 9.44% |
| 1997 Q1 | 1.96 Billion USD | -5.38% |
| 1997 Q2 | 2.07 Billion USD | 5.18% |
| 1997 Q3 | 1.98 Billion USD | -4.11% |
| 1996 FY | 7.66 Billion USD | 10.1% |
| 1996 Q4 | 2.08 Billion USD | 15.04% |
| 1996 Q3 | 1.8 Billion USD | -6.51% |
| 1996 Q2 | 1.93 Billion USD | 4.94% |
| 1996 Q1 | 1.84 Billion USD | -8.45% |
| 1995 Q4 | 2.01 Billion USD | 24.88% |
| 1995 Q3 | 1.61 Billion USD | -8.41% |
| 1995 Q2 | 1.76 Billion USD | 11.53% |
| 1995 Q1 | 1.57 Billion USD | -7.72% |
| 1995 FY | 6.96 Billion USD | 16.65% |
| 1994 Q1 | 1.34 Billion USD | -38.06% |
| 1994 Q4 | 1.71 Billion USD | 23.91% |
| 1994 Q3 | 1.38 Billion USD | -10.16% |
| 1994 Q2 | 1.53 Billion USD | 14.54% |
| 1994 FY | 5.96 Billion USD | -5.09% |
| 1993 Q4 | 2.16 Billion USD | 60.13% |
| 1993 FY | 6.28 Billion USD | -5.2% |
| 1993 Q1 | 1.31 Billion USD | -39.26% |
| 1993 Q2 | 1.45 Billion USD | 11.2% |
| 1993 Q3 | 1.35 Billion USD | -7.33% |
| 1992 Q4 | 2.16 Billion USD | 39.63% |
| 1992 Q2 | 1.53 Billion USD | 10.12% |
| 1992 Q1 | 1.39 Billion USD | -15.37% |
| 1992 FY | 6.63 Billion USD | 16.2% |
| 1992 Q3 | 1.54 Billion USD | 0.85% |
| 1991 Q3 | 1.32 Billion USD | -3.64% |
| 1991 FY | 5.7 Billion USD | 8.1% |
| 1991 Q4 | 1.64 Billion USD | 24.23% |
| 1991 Q2 | 1.37 Billion USD | 0.88% |
| 1991 Q1 | 1.36 Billion USD | -13.07% |
| 1990 Q4 | 1.56 Billion USD | 25.84% |
| 1990 FY | 5.28 Billion USD | -6.46% |
| 1990 Q2 | 1.24 Billion USD | 1.39% |
| 1990 Q1 | 1.22 Billion USD | 115.11% |
| 1990 Q3 | 1.24 Billion USD | 0.32% |
| 1989 Q4 | -8.1 Billion USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | 5.64 Billion USD | 25.77% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbbVie Inc. | 24.83 Billion USD | -38.164% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | 0.0% |
| Johnson & Johnson | 58.6 Billion USD | 41.451% |
| Eli Lilly and Company | 16.71 Billion USD | -105.264% |
| Merck & Co., Inc. | 43.98 Billion USD | 21.996% |
| Novartis AG | 24.87 Billion USD | -37.964% |
| Organon & Co. | 2.41 Billion USD | -1318.479% |
| Pfizer Inc. | 25.45 Billion USD | -34.825% |